BioPharma Dive June 24, 2024
Clare Campbell-Cooper, Global Head of Digital Health and Innovation at FORTREA

Sponsored content By Fortrea

Diseases aren’t just disorders in physiological systems, and it’s not possible to cure them simply by discovering molecules with therapeutic effects on cellular targets. Instead, as research from the National Institutes of Health (NIH) reminds us, diseases affect individuals who live in communities, and an enormous array of social, economic, psychological and environmental factors determine their prevalence, transmission and outcomes.

Applying a systems thinking approach to clinical trial design addresses this holistic perspective. In systems thinking, we consider all the factors that influence health — and the dynamics and interactions between them — when planning and executing studies. By nature, systems are complex entities. When we understand the relationships between the parts and the whole,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, Trends
FDA approves clinical trials for pig organ transplants
Supply chains and AI take precedence at European clinical trial meeting
Clinical trial: New drug combination reduces anemia in rare blood disorder
Transforming Clinical Trials with Alexander Saint-Amand
The New Product Development Landscape: Navigating the Challenges

Share This Article